Long-term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Allam, Anthony K
Goss, John A
Kowdley, Kris V
Journal titleLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Publication Begin page15
Publication End page25
MetadataShow full item record
AbstractThere have been conflicting data regarding liver transplantation (LT) outcomes for hereditary hemochromatosis (HH), with no recent data on LT outcomes in patients with HH in the past decade. Using the United Network for Organ Sharing registry, we evaluated waitlist and post-LT survival in all adult patients listed for HH without concomitant liver disease from 2003 to 2019. Post-LT survival for HH was compared with a propensity-matched (recipient and donor factors) cohort of recipients with chronic liver disease (CLD). From 2003 to 2019, 862 patients with HH were listed for LT, of which 55.6% ( n = 479) patients underwent LT. The 1- and 5-year post-LT survival rates in patients with HH were 88.7% (95% confidence interval [CI], 85.4%-91.4%) and 77.5% (95% CI, 72.8%-81.4%), respectively, and were comparable with those in the propensity-matched CLD cohort ( p value = 0.96). Post-LT survival for HH was lower than for Wilson's disease, another hereditary metabolic liver disease with similar LT volume ( n = 365). Predictors for long-term (5-year) post-LT mortality included presence of portal vein thrombosis (hazard ratio [HR], 1.96; 95% CI, 1.07-3.58), obesity measurements greater than Class II (HR, 1.98; 95% CI, 1.16-3.39), and Karnofsky performance status (HR, 0.98; 95% CI, 0.97-0.99) at the time of LT. The leading cause of post-LT death ( n = 145) was malignancy (25.5%), whereas cardiac disease was the cause in less than 10% of recipients. In conclusion, short- and long-term survival rates for HH are excellent and comparable with those of other LT recipients. Improving extrahepatic metabolic factors and functional status in patients with HH prior to LT may improve outcomes.
CitationLymberopoulos P, Prakash S, Shaikh A, Bhatnagar A, Allam AK, Goli K, Goss JA, Kanwal F, Rana A, Kowdley KV, Jalal P, George Cholankeril. Long-term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States. Liver Transpl. 2023 Jan 1;29(1):15-25. doi: 10.1002/lt.26539. Epub 2022 Jul 21. PMID: 35770428; PMCID: PMC9800641.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Copyright © 2022 American Association for the Study of Liver Diseases.
- Survival of liver transplant recipients with hemochromatosis in the United States.
- Authors: Yu L, Ioannou GN
- Issue date: 2007 Aug
- Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
- Authors: Bardou-Jacquet E, Philip J, Lorho R, Ropert M, Latournerie M, Houssel-Debry P, Guyader D, Loréal O, Boudjema K, Brissot P
- Issue date: 2014 Mar
- Modern Outcomes Following Treatment of Hepatocellular Carcinoma in Hereditary Hemochromatosis: A Matched Cohort Study.
- Authors: McPhail MJW, Khorsandi SE, Abbott L, Al-Kadhimi G, Kane P, Karani J, O'Grady J, Heaton N, Bomford A, Suddle A
- Issue date: 2019 Dec
- Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
- Authors: Kowdley KV, Brandhagen DJ, Gish RG, Bass NM, Weinstein J, Schilsky ML, Fontana RJ, McCashland T, Cotler SJ, Bacon BR, Keeffe EB, Gordon F, Polissar N, National Hemochromatosis Transplant Registry
- Issue date: 2005 Aug
- Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis.
- Authors: Crawford DH, Fletcher LM, Hubscher SG, Stuart KA, Gane E, Angus PW, Jeffrey GP, McCaughan GW, Kerlin P, Powell LW, Elias EE
- Issue date: 2004 Jun